Patent · US Expired

ECB deacylase mutants

US6361988B1 · kind B1 · utility

14Cited by
1References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 4, 2000
Grant dateMar 26, 2002
Priority date
Expiry dateApr 4, 2020

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N9/80
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

A method for in vitro mutagenesis and recombination of polynucleotide sequences based on polymerase-catalyzed extension of primer oligonucleotides is disclosed. The method involves priming template polynucleotide(s) with random-sequences or defined-sequence primers to generate a pool of short DNA fragments with a low level of point mutations. The DNA fragments are subjected to denaturization followed by annealing and further enzyme-catalyzed DNA polymerization. This procedure is repeated a sufficient number of times to produce full-length genes which comprise mutants of the original template polynucleotides. These genes can be further amplified by the polymerase chain reaction and cloned into a vector for expression of the encoded proteins.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.